NYSE:MDTMedical Equipment
Medtronic (NYSE:MDT) Prepares for Diabetes Unit Spin-Off with New CFO Appointment
Medtronic (NYSE:MDT) experienced a price increase of 7% over the last quarter, which may have been influenced by notable corporate developments and robust financial performance. The company announced Chad Spooner's appointment as CFO of MiniMed, a step vital for its separation initiative. Medtronic's financial results showed solid growth, with annual sales rising to $33,537 million and net income reaching $4,662 million. Meanwhile, its dividend increase to $0.71 per share reflects shareholder...